Literature DB >> 22210682

Anti-tumor necrosis factor inhibitor therapy-induced dermatomyositis and fasciitis.

Giovanna Riolo, Tanveer E Towheed.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22210682

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  12 in total

Review 1.  Treatment of inflammatory myopathy: emerging therapies and therapeutic targets.

Authors:  Siamak Moghadam-Kia; Rohit Aggarwal; Chester V Oddis
Journal:  Expert Rev Clin Immunol       Date:  2015-08-27       Impact factor: 4.473

Review 2.  Recent Advances in Pharmacological Treatments of Adult Dermatomyositis.

Authors:  Kristen L Chen; Majid Zeidi; Victoria P Werth
Journal:  Curr Rheumatol Rep       Date:  2019-08-31       Impact factor: 4.592

Review 3.  Treatment in myositis.

Authors:  Chester V Oddis; Rohit Aggarwal
Journal:  Nat Rev Rheumatol       Date:  2018-03-29       Impact factor: 20.543

Review 4.  The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis: a Critical Review.

Authors:  Angela Ceribelli; Maria De Santis; Natasa Isailovic; M Eric Gershwin; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

5.  Moderate endurance and muscle training is beneficial and safe in patients with quiescent or mildly active Crohn's disease.

Authors:  Wolfgang Alexander Seeger; Juliane Thieringer; Philip Esters; Benjamin Allmendinger; Jürgen Stein; Hermann Schulze; Axel Dignass
Journal:  United European Gastroenterol J       Date:  2020-06-25       Impact factor: 4.623

6.  High Serum Creatine Kinase Levels in Infliximab and Vedolizumab-Treated Inflammatory Bowel Disease Patients.

Authors:  Manuel Sutter; Petr Hruz; Jan Hendrik Niess
Journal:  Inflamm Intest Dis       Date:  2021-08-26

Review 7.  Secondary Causes of Myositis.

Authors:  Sarah H Berth; Thomas E Lloyd
Journal:  Curr Treat Options Neurol       Date:  2020-10-06       Impact factor: 3.598

Review 8.  Cutaneous dermatomyositis in the era of biologicals.

Authors:  Natalie A Wright; Ruth Ann Vleugels; Jeffrey P Callen
Journal:  Semin Immunopathol       Date:  2015-11-12       Impact factor: 9.623

Review 9.  Modern Therapies for Idiopathic Inflammatory Myopathies (IIMs): Role of Biologics.

Authors:  Siamak Moghadam-Kia; Chester V Oddis; Rohit Aggarwal
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

Review 10.  New onset of dermatomyositis/polymyositis during anti-TNF-α therapies: a systematic literature review.

Authors:  Alexandra Maria Giovanna Brunasso; Werner Aberer; Cesare Massone
Journal:  ScientificWorldJournal       Date:  2014-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.